We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.60
Bid: 28.50
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.754%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 28.60
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Hvivo plc

3 Jan 2020 14:18

RNS Number : 7365Y
IP Group PLC
03 January 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

IP Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

hVIVO plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

13,063,883

15.72

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

13,063,883

15.72

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

None

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

None

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

None

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

None

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

None

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

23 December 2019

Contact name:

Greg Smith

Telephone number:

0207 444 0050

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETKKNBDQBKDDDK
Date   Source Headline
3rd Oct 20199:51 amRNSDirector's Dealings
2nd Oct 20195:03 pmRNSExercise of Share Options
27th Sep 20197:00 amRNShVIVO to present at ERS International Congress
19th Sep 20197:00 amRNSInterim Results 2019
23rd Aug 20197:00 amRNSNotice of Interim Results
6th Aug 20197:00 amRNSSuccessful RSV Challenge Study in Older Adults
31st Jul 20197:00 amRNSPhase 1 clinical trial of AGS-v PLUS
31st Jul 20197:00 amRNSFinance Director
25th Jul 20193:15 pmRNSExercise of Share Options
25th Jul 20193:10 pmRNSExercise of Share Options
16th Jul 20197:00 amRNSExercise of Share Options
9th Jul 20194:00 pmRNSHolding(s) in Company
9th Jul 201911:00 amRNSHolding(s) in Company
2nd Jul 20191:45 pmRNSDirector's Dealings
26th Jun 20194:10 pmRNSExercise of Share Options
17th Jun 20197:00 amRNSRSV Challenge Model Delivers Positive Results
14th Jun 201912:00 pmRNSExercise of Share Options
31st May 201912:00 pmRNSResult of AGM
21st May 20197:00 amRNSExercise of Share Options
26th Apr 20199:56 amRNS2018 Annual Report and Financial Statements
11th Apr 20197:00 amRNSPreliminary Results 2018
1st Apr 20191:21 pmRNSDirector's Dealings
29th Mar 20197:00 amRNShVIVO and Imutex to present at IVW 2019
21st Mar 201910:34 amRNSExercise of Share Options
8th Mar 20197:00 amRNSNotice of Preliminary Results
30th Jan 20199:55 amRNSHolding(s) in Company
24th Jan 201910:12 amRNSShare Incentive Plan and PDMR Dealings
10th Jan 20197:00 amRNSPositive data for Phase IIb FLU-v challenge study
4th Jan 20194:00 pmRNSDirector's Dealings
4th Jan 201910:02 amRNSAward of Share Options
2nd Jan 20197:00 amRNSDirectorate Change
20th Nov 20187:00 amRNSExercise of Share Options
31st Oct 20187:00 amRNSPartial preliminary results for NIH study of AGS-v
8th Oct 20182:00 pmRNSDirector's Dealings
8th Oct 20187:02 amRNSTwo new contracts for RSV human challenge studies
8th Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSNotification of Major Holdings
28th Sep 201811:00 amRNSNotification of Major Holdings
20th Sep 20187:00 amRNSHalf-year Report
18th Sep 20187:00 amRNSExercise of Share Options
10th Sep 20187:00 amRNSNotification of Major Interest in Shares
29th Aug 20182:00 pmRNSNotification of Major Interest in Shares
29th Aug 20187:00 amRNSNotification of Major Interest in Shares
21st Aug 201811:00 amRNSExercise of Share Options
20th Aug 20187:00 amRNSNotification of Major Interest in Shares
16th Aug 20187:00 amRNSNotice of Interim Results
13th Aug 20187:00 amRNSAward of Share Options
10th Aug 20187:00 amRNSDirector's Dealings
10th Aug 20187:00 amRNSExercise of Share Options
27th Jul 20187:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.